Kazia Therapeutics Limited (KZIA) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师共识目标价为 $18.00, 上涨空间为 80% 相对于当前价格 $10.00.
分析师预估 每股收益(EPS)为 $-44.91 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-55.85 vs 预期 $-44.91 (不及预期 -24.4%). 2025: 实际 $-18.90 vs 预期 $-0.02 (不及预期 -94417.6%). 分析师准确度: 40%.
KZIA 股票 — 12个月价格预测
$18.00
▲ +80.00% 上涨空间
平均目标价
Based on 2 Wall Street analysts offering 12-month price targets for Kazia Therapeutics Limited, the price target is $18.00.
平均目标价相对最新价格 $10.00 变动 +80.00%。
KZIA 分析师评级
Buy
基于过去3个月内 2 位分析师对 Kazia Therapeutics Limited 的评级
EPS 预测 — KZIA
40%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$55.85
vs Est –$44.91
▼ 19.6% off
2025
Actual –$18.90
vs Est –$0.02
▼ 99.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — KZIA
23%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.002B
vs Est $0.000B
▲ 93.5% off
2025
Actual $0.000B
vs Est $0.000B
▼ 59.5% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
